Fair Value Measurements (Tables)

9 Months Ended

Sep. 27, 2024

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities at carrying and fair value

A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):

	Quoted Prices in Active Market (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
September 27, 2024:
Assets:
Investments in rabbi trust	$	16.0	$	8.3	$	—	$	24.3
Liabilities:
Cross-currency swap derivative contract	$	—	$	5.0	$	—	$	5.0
Deferred compensation plans	$	—	$	24.3	$	—	$	24.3
Contingent consideration	$	—	$	—	$	2.0	$	2.0
December 31, 2023:
Liabilities:
Cross-currency swap derivative contract	$	—	$	3.3	$	—	$	3.3
Deferred compensation plans	$	—	$	21.4	$	—	$	21.4
Contingent consideration	$	—	$	—	$	3.8	$	3.8

The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):

	September 27, 2024				December 31, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets:
Investments in rabbi trust	$	24.3	$	24.3	$	—	$	—
Liabilities:
Contingent consideration	$	2.0	$	2.0	$	3.8	$	3.8
Cross-currency swap derivative contract	$	5.0	$	5.0	$	3.3	$	3.3
Convertible senior notes due 2028	$	489.0	$	453.8	$	486.9	$	455.7
Convertible senior notes due 2025	$	115.8	$	127.3	$	115.3	$	145.1
Other debt	$	816.6	$	816.6	$	911.2	$	911.2